Fitzgerald M F, Parente L, Whittle B J
Department of Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, U.K.
Eur J Pharmacol. 1989 May 30;164(3):539-46. doi: 10.1016/0014-2999(89)90262-8.
Adherent guinea-pig alveolar macrophages stimulated in vitro with FMLP (1 microM) for 5-60 min released PAF-acether, TXB2 and LTB4, with maximal levels being achieved after a 5 min incubation. The levels of eicosanoids were maintained during the 60 min incubation period, whereas the levels of PAF-acether decreased and were no longer detectable after 60 min incubation. Indomethacin (1 microM) completely suppressed the release of TXB2 stimulated by FMLP (1 microM for 5 min) whilst potentiating the release of LTB4. The selective 5-lipoxygenase inhibitor, BW A137C (1 microM), abolished the stimulated release of LTB4 without affecting the release of TXB2. BW755C (1-20 microM) caused a dose-related inhibition of TXB2 release but did not affect LTB4 release, while none of the drugs studied affected the release of PAF-acether. These results indicate that the FMLP-induced release of PAF-acether from guinea-pig alveolar macrophages is not susceptible to modulation by selective inhibition of lipoxygenase or cyclo-oxygenase and is therefore not secondary to the synthesis of LTB4 or TXB2.
用FMLP(1微摩尔)在体外刺激贴壁豚鼠肺泡巨噬细胞5 - 60分钟,可释放血小板活化因子 - 乙酰醚(PAF - acether)、血栓素B2(TXB2)和白三烯B4(LTB4),孵育5分钟后达到最高水平。在60分钟孵育期内,类花生酸水平保持稳定,而PAF - acether水平下降,孵育60分钟后不再能检测到。吲哚美辛(1微摩尔)完全抑制了FMLP(1微摩尔,作用5分钟)刺激的TXB2释放,同时增强了LTB4的释放。选择性5 - 脂氧合酶抑制剂BW A137C(1微摩尔)消除了刺激的LTB4释放,而不影响TXB2的释放。BW755C(1 - 20微摩尔)引起与剂量相关的TXB2释放抑制,但不影响LTB4释放,而所研究的药物均不影响PAF - acether的释放。这些结果表明,FMLP诱导的豚鼠肺泡巨噬细胞PAF - acether释放不易受到脂氧合酶或环氧化酶选择性抑制的调节,因此不是LTB4或TXB2合成的继发结果。